A federal judge has blocked a Mississippi law that would ban abortions 6 weeks into pregnancy; Teva Pharmaceuticals settled with state of Oklahoma for $85 million 2 days before opioid trials were set to begin; the governor of Maine has signed a bill that will remove nonmedical exemptions for vaccinations.
On Friday, US District Judge Carlton Reeves blocked a Mississippi law that would have banned abortions as early as 6 weeks into pregnancy, when a fetal heartbeat can usually be detected, CNN reported. In a preliminary injunction, Reeves said the law threatened women’s rights, as most do not seek an abortion until after 6 weeks of pregnancy. Similar “heartbeat” bills to limit abortion have been introduced in 15 states this year.
Litigation against Johnson & Johnson, a major opioid manufacturer, will begin in Oklahoma today, Kaiser Health News reported. Oklahoma Attorney General Mike Hunter alleged that the company overstated the benefits of opioids and understated their risks in marketing campaigns, encouraging physicians to prescribe them for ailments not approved by regulators. Teva Pharmaceuticals, which was also set to face trial, announced an $85 million settlement with the state on Sunday, leaving Johnson & Johnson as the sole defendant.
Maine Governor Janet Mills signed a bill into law on Friday that will end most nonmedical exemptions for mandatory childhood vaccines, according to The Hill. The law will allow only physicians and pediatric primary care givers to determine whether a child should receive a medical exemption. Maine will become the fourth state to remove religious exemptions for vaccine requirements.
Age Alone Is No Barrier to Allo-HCT for AML, Data Indicate
April 17th 2024A new study is among the largest real-world analyses to date to assess trends over time and predictive factors for older patients with acute myeloid leukemia (AML) who received allogeneic hematopoietic cell transplantation (allo-HCT).
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from the Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen